Medicxi Ventures Management (Jersey) Ltd's Net Worth
-$21.7 Million
Who is Medicxi Ventures Management (Jersey) Ltd?
Medicxi Ventures Management (Jersey) Ltd does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., Centessa Pharmaceuticals plc, and Aura Biosciences, Inc..
SEC CIK
Medicxi Ventures Management (Jersey) Ltd's CIK is 0001715579
Past Insider Trading and Trends
2021 was Medicxi Ventures Management (Jersey) Ltd's most active year for acquiring shares with 18 total transactions. Medicxi Ventures Management (Jersey) Ltd's most active month to acquire stocks was the month of October. 2021 was Medicxi Ventures Management (Jersey) Ltd's most active year for disposing of shares, totalling 8 transactions. Medicxi Ventures Management (Jersey) Ltd's most active month to dispose stocks was the month of October. 2021 saw Medicxi Ventures Management (Jersey) Ltd paying a total of $24,366,684.39 for 5,771,710 shares, this is the most they've acquired in one year. In 2021 Medicxi Ventures Management (Jersey) Ltd cashed out on 4,261,710 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Centessa Pharmaceuticals plc (CNTA) Snapshot price: $7.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.08% | 1.84M |
—
|
—
| 11.48M |
Mar 21
| |||
Form 4
| +0.86% | 34.33K |
$12.82 | $440,059.32 | 4.03M |
Dec 2
| |||
Form 4
| +1.24% | 97.15K |
$12.12 | $1,189,198.62 | 7.93M |
Nov 30 - Dec 1
| |||
Form 4
| +0.89% | 68.52K |
$11.52 | $797,426.45 | 7.74M |
Nov 26 - Nov 29
| |||
Form 4
| +55.90% | 2.53M |
$20.00 | $12,000,000.00 | 7.06M |
Jun 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aura Biosciences, Inc. (AURA) Snapshot price: $8.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.04M |
$14.00 |
—
| 3.04M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||